Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, ProPhase Labs, Inc. reported revenue of $4M, down 35.8% year over year. Operating margin was -415.4% and net margin -339.3%, on a free-cash-flow margin of -192.0% with capital expenditure at 0.0% of revenue. Every figure is computed directly from PRPH's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $4M | -415.4% | -339.3% |
| FY2024 | $7M | -570.6% | -788.2% |
| FY2023 | $35M | -60.7% | -48.0% |
| FY2022 | $123M | 19.2% | 15.1% |
| FY2021 | $79M | 12.4% | 7.9% |
How does PRPH compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.